Pro-Dex, Inc. (PDEX)
66.26
+0.59
(+0.90%)
USD |
NASDAQ |
Aug 24, 16:00
66.26
0.00 (0.00%)
After-Hours: 20:00
Pro-Dex Shareholders Equity (Quarterly) : 45.20M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 45.20M |
| December 31, 2025 | 41.63M |
| September 30, 2025 | 41.51M |
| June 30, 2025 | 36.63M |
| March 31, 2025 | 35.28M |
| December 31, 2024 | 31.82M |
| September 30, 2024 | 30.88M |
| June 30, 2024 | 30.87M |
| March 31, 2024 | 30.94M |
| December 31, 2023 | 31.79M |
| September 30, 2023 | 31.20M |
| June 30, 2023 | 31.59M |
| March 31, 2023 | 25.84M |
| December 31, 2022 | 24.47M |
| September 30, 2022 | 24.42M |
| June 30, 2022 | 25.43M |
| March 31, 2022 | 22.27M |
| December 31, 2021 | 22.00M |
| September 30, 2021 | 21.38M |
| June 30, 2021 | 20.08M |
| March 31, 2021 | 20.08M |
| December 31, 2020 | 21.84M |
| September 30, 2020 | 20.05M |
| June 30, 2020 | 19.06M |
| March 31, 2020 | 17.16M |
| Date | Value |
|---|---|
| December 31, 2019 | 17.87M |
| September 30, 2019 | 17.44M |
| June 30, 2019 | 17.01M |
| March 31, 2019 | 17.65M |
| December 31, 2018 | 16.98M |
| September 30, 2018 | 17.73M |
| June 30, 2018 | 17.28M |
| March 31, 2018 | 17.43M |
| December 31, 2017 | 16.74M |
| September 30, 2017 | 16.28M |
| June 30, 2017 | 13.71M |
| March 31, 2017 | 12.96M |
| December 31, 2016 | 12.20M |
| September 30, 2016 | 9.126M |
| June 30, 2016 | 8.877M |
| March 31, 2016 | 9.14M |
| December 31, 2015 | 8.766M |
| September 30, 2015 | 8.36M |
| June 30, 2015 | 8.478M |
| March 31, 2015 | 8.402M |
| December 31, 2014 | 8.883M |
| September 30, 2014 | 9.062M |
| June 30, 2014 | 9.216M |
| March 31, 2014 | 7.671M |
| December 31, 2013 | 8.047M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.98M |
| Total Liabilities (Quarterly) | 29.78M |
| Debt to Equity Ratio | 0.4463 |
| Current Ratio | 3.667 |
| Net Debt Paydown Yield | -0.30% |